BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, December 11, 2025
Home
»
Newsletters
» BioWorld
BioWorld
April 15, 2005
View Archived Issues
FDA Seen As More Stringent Regarding Drug Safety Issues
Read More
Xsira Licenses Clinical-Stage Adenosine-Based Compound
Read More
Other News To Note
Read More
Appointments And Advancements
Read More
Stressgen Sells Bioreagents Unit To Better Focus On Lead Product
Concentrating its efforts on its lead drug, HspE7, Stressgen Biotechnologies Corp. agreed to divest its bioreagents business in a move that adds a bit of capital to its coffers. (BioWorld Today)
Read More
Deal Transforming Bionaut From Platform To Products
Read More
